Home Print E-mail
Alan J. Bernstein

Alan J. Bernstein

Partner
Co-chair, Practice Development Committee

Wall Street Office
2 Wall Street
New York, NY 10005
bernstein@clm.com
phone: 212-238-8795
fax: 212-732-3232 download v-card

Practice Areas

Corporate, M&A Transactions, Securities

Practice Description

General corporate practice and representation with a concentration on transactions for technology companies and cross-border deals. Substantial experience in: public offerings and private placements, representing issuers and underwriters in initial public offerings, secondary offerings and venture capital investments; mergers and acquisitions, representing buyers and sellers in negotiated stock and asset purchases; and licensing and strategic partnering.

Education

  • B.A., 1979 Stanford University
  • J.D., 1983 Boalt Hall School of Law, University of California, Berkeley

Admissions

1984 New York

Affiliations

  • Board of Trustees, Archive of Contemporary Music
  • 2000-2004 Board of Editors, Advising Start Up and Emerging Companies
  • New York State Bar Association
  • American Bar Association (Member, Section of Business Law)

Publications Available on this website...

"Current Trends in Venture Capital," Client Advisory, March 2005; ""Going Private" After The Sarbanes-Oxley Act of 2002," Client Advisory, January 2003; "Gold Rush-Buying Pieces of Distressed Companies," The Daily Deal, October 23, 2002

Additional Publications

CL&M Gateways: Useful News for Tech Companies Coming to America, Editor (periodic newsletter); "Pursuing Strategic Investment Opportunities," New York Law Journal, September 17, 2001 (co- authored)

Presentations

“Negotiating Terms For Venture Capital Investments;” “Liquidity Events for Portfolio Companies” - Presentations at Annual Meetings of Community Development Venture Capital Alliance, March 2005 and March 2007

Illustrative Matters

Client
Description
Trinity Biotech plc
Represented Irish biotechnology company in its key technology licensing and marketing agreement, followed by initial public offering. Represented the company in its merger with another publicly-held biotechnology company and the public distribution of its shares. Numerous acquisitions and private financings, including PIPEs.
Screaming Media, Inc.
Represented web content aggregator in $5 million angel financing round and $30 million mezzanine round; established key license agreements with content providers and ecommerce customers.
Dako Cytomation A/S
Represented biotechnology equipment maker in merger with Danish buyer and then represented merged Danish company in acquisition and joint venture licensing.
Spectel Ltd.
Represented Irish internet teleconferencing company in strategic acquisition of U.S. operations and sale of the company to major Telecom.
RightAnswers, Inc.
Represented application service provider in spin-off from public parent and follow-on private placements, including recent venture capital rounds.
Medidata Solutions, Inc.
Represented maker of online solutions for clinical trials in private financing and licensing transactions.
Content Directions, Inc.
Represented digital content manager in angel financing and transactions with publishers.
Avnet, Inc.
Represented Avnet, Inc. in numerous venture capital investments and strategic alliances.
Community Development Venture Capital Alliance
Pro bono representation of not-for-profit alliance assisting venture funds which make use of capital investments to create jobs and wealth for low-income people and distressed communities.
American Friends of Israel Crisis Center
Pro bono representation of U.S. fundraising arm of Israeli non-profit helping immigrant victims of terror and misfortune.